Valneva and Pfizer start new Phase 2 study for Lyme disease vaccine candidate
Valneva and Pfizer have initiated a Phase 2 study for their Lyme disease vaccine candidate: which is the only active Lyme disease vaccine in clinical development today.
Archives for March 8, 2021
Survey reveals site team thoughts about advanced technologies
The DT Clinical Trial Digital Tracker Survey indicates many trial professionals often are hesitant to dive fully into digital technology integration.
ObvioHealth announces upgraded decentralized trial platform
The company’s technology facilitates remote patient monitoring and integrates with a wide range of wearable sensors for checking patient vital signs.